Ex Parte Herndon - Page 1



                           The opinion in support of the decision being entered today was not written                   
                                   for publication and is not binding precedent of the Board.                           
                                                                                           Paper No. 18                 
                         UNITED STATES PATENT AND TRADEMARK OFFICE                                                      
                                                    __________                                                          

                              BEFORE THE BOARD OF PATENT APPEALS                                                        
                                             AND INTERFERENCES                                                          
                                                     __________                                                         
                                           Ex parte DAVID N. HERNDON                                                    
                                                    ___________                                                         
                                                Appeal No. 2004-2170                                                    
                                             Application No. 09/901,429                                                 
                                                     __________                                                         
                                                      ON BRIEF                                                          
                                                     __________                                                         
              Before SCHEINER, ADAMS and GRIMES, Administrative Patent Judges.                                          
              SCHEINER, Administrative Patent Judge.                                                                    
                                               DECISION ON APPEAL                                                       
                     This is a decision on appeal under 35 U.S.C. § 134 from the final rejection of                     
              claims 1-7 and 9-12.  Claims 14-20 are also pending, but have been withdrawn from                         
              further consideration by the examiner.                                                                    
                     Claims 1, 3, 4 and 9 are representative of the subject matter on appeal:                           
                     1.  A method of treating an individual having a severe burn, comprising the step                   
              of administering to said individual a pharmacologically effective dose of a beta-                         
              adrenergic antagonist, wherein treatment with said beta-adrenergic antagonist improves                    
              skeletal muscle protein kinetics in said individual as compared to [an] individual without                
              said treatment.                                                                                           
                     3.  The method of claim 2, wherein said beta-adrenergic antagonist is                              
              administered in a dose that decrease[s] heart rate in said individual by about 25%.                       
                     4.  The method of claim 2, wherein said beta-adrenergic antagonist is                              
              administered in a dose of from about 0.1 mg/kg of the body weight of the individual to                    
              about 10 mg/kg of the body weight of the individual.                                                      
                     9.  A method of treating an individual having a severe burn, comprising the step                   
              of administering to said individual a pharmacologically effective dose of propranolol,                    



Page:  1  2  3  4  5  6  7  Next 

Last modified: November 3, 2007